AVE LAUNCHES MICRO STENT II, SLATES GFX SHIPMENTS FOR MARCH FOLLOWING DEC. 23 FDA APPROVAL; RAPID EXCHANGE DELIVERY SYSTEM IN CLINICALS
This article was originally published in The Gray Sheet
Executive Summary
Arterial Vascular Engineering is planning to launch its Micro Stent II and gfx coronary stent systems in two phases following premarket approval application clearance by FDA on Dec. 23, the company says. Shipments of the Micro Stent II will commence immediately while roll out of the gfx is scheduled for March following inventory ramp up.